All times are listed in CEST (Central European Summer Time)

Displaying One Session

View
Controversy session

What is the optimal 2nd line treatment for metastatic somatostatin-receptor positive, liver-dominant midgut NET?

Date
Sun, 19.09.2021
Time
16:45 - 17:20
Location
Channel 6
Chairs
  • Marianne E. Pavel (Erlangen, Germany)
Controversy session

Introduction by the chair

Speakers
  • Marianne E. Pavel (Erlangen, Germany)
Lecture Time
16:45 - 16:48
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Sun, 19.09.2021
Time
16:45 - 17:20
Controversy session

Polling 1 (led by chair)

Speakers
  • Marianne E. Pavel (Erlangen, Germany)
Lecture Time
16:48 - 16:49
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Sun, 19.09.2021
Time
16:45 - 17:20
Controversy session

177Lu-dotatate

Speakers
  • Eric Baudin (Villejuif, CEDEX, France)
Lecture Time
16:49 - 16:59
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Sun, 19.09.2021
Time
16:45 - 17:20
Controversy session

Hepatic arterial embolization

Speakers
  • Jonathan R. Strosberg (Tampa, United States of America)
Lecture Time
16:59 - 17:09
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Sun, 19.09.2021
Time
16:45 - 17:20
Controversy session

Polling 2 (led by chair)

Speakers
  • Marianne E. Pavel (Erlangen, Germany)
Lecture Time
17:09 - 17:10
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Sun, 19.09.2021
Time
16:45 - 17:20
Controversy session

Q&A

Speakers
  • Marianne E. Pavel (Erlangen, Germany)
Lecture Time
17:10 - 17:20
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Sun, 19.09.2021
Time
16:45 - 17:20